Oncolytics Biotech Inc insider trading
Every open-market purchase and sale by Oncolytics Biotech Inc's officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
Insider purchases, 5 years $363,232 14 trades by 10 insiders
3 months later: median +4.8% (−5.3% vs S&P 500) Insider sales, 5 years $0 0 trades by 0 insiders
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Oncolytics Biotech Inc’s insiders pay?
From January 20, 2026 to March 13, 2026, 9 insiders reported 10 open-market purchases and 0 sales not made under a pre-set plan in Oncolytics Biotech Inc.
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Seizinger Bernd R. | Director | 2 | — | — | 0 | — | February 13, 2026 |
| Andrews Patricia S | Director | 1 | — | — | 0 | — | February 13, 2026 |
| Aromando Andrew | Chief Business Officer | 1 | — | — | 0 | — | February 13, 2026 |
| Brown Deborah Margaret | Director | 1 | — | — | 0 | — | February 13, 2026 |
| Heineman Thomas Charles | Chief Medical Officer | 1 | — | — | 0 | — | February 13, 2026 |
| Kelly Jared | Chief Executive Officer | 1 | — | — | 0 | — | February 13, 2026 |
| Look Kirk | Chief Financial Officer | 1 | — | — | 0 | — | February 13, 2026 |
| Parsons James T. | Director | 1 | — | — | 0 | — | March 13, 2026 |
| Pisano Wayne | Director | 1 | — | — | 0 | — | February 13, 2026 |